FDA/USDA Regulations - Biotech/Drug Laws | National Law Review  

June 25, 2020

Volume X, Number 177

June 24, 2020

Subscribe to Latest Legal News and Analysis

June 23, 2020

Subscribe to Latest Legal News and Analysis

June 22, 2020

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
24
Jun
New Florida Legislation Expands Pharmacist Scope of Practice Greenberg Traurig, LLP
24
Jun
Citizen’s Petition Filed for FDA Pathway to Legally Market Supplements With CBD Faegre Drinker
24
Jun
If you Handle PFAS, Your TRI May Be Different Next Year Beveridge & Diamond PC
24
Jun
California Judge Dismisses Proposed Class Action Against Kellogg Vanilla Labeling Keller and Heckman LLP
23
Jun
Ninth Circuit Rejects Plaintiffs’ Claims in Trio of ADA Disability Access Cases Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
23
Jun
Update on FDA’s Comprehensive Regenerative Medicine Framework: Looming November 2020 Deadline Preceded by a Flurry of Letters from CBER and a New JAMA Editorial Mintz
23
Jun
FDA Adds QR Code to Certain Food Export Certificates Keller and Heckman LLP
23
Jun
FDA Issue Guidance on Manufacturing Drugs, APIs during COVID-19 Sheppard, Mullin, Richter & Hampton LLP
22
Jun
Trial Concludes in Challenge to EPA’s Denial of Fluoride Petition Bergeson & Campbell, P.C.
22
Jun
Biogen v. Mylan: When Does a Specification Fail to Describe a Newly-Presented Claim? Schwegman, Lundberg & Woessner, P.A.
22
Jun
New Citizens Petition Requests FDA Status for Hemp-Derived CBD in Dietary Supplements Keller and Heckman LLP
22
Jun
Temporary Food Labeling Policies in Light of the COVID-19 Pandemic Polsinelli PC
19
Jun
Transatlantic Trade: US and European Trade Talk Update – June 19, 2020 Squire Patton Boggs (US) LLP
19
Jun
California Employers Face Broader Recording and Reporting Obligations for COVID-19 Illnesses Beveridge & Diamond PC
19
Jun
Not Today Corona: EEOC Prohibits Testing Employees for Antibodies Sheppard, Mullin, Richter & Hampton LLP
19
Jun
FDA’s Revocation of the Hydroxychloroquine and Chloroquine EUA May Test the Limits of PREP Act Immunity Faegre Drinker
19
Jun
Federal Court Vacates Nationwide Permit 48 for Local Commercial Shellfish Growers Beveridge & Diamond PC
19
Jun
FSIS Publishes Notice to Expand STEC Testing in Beef Products Keller and Heckman LLP
18
Jun
Price Gouging and Services: Third-Party Food Delivery Price Gouging? Proskauer Rose LLP
18
Jun
President Of Medical Technology Company Charged For Promoting Fake COVID-19 Treatment Sheppard, Mullin, Richter & Hampton LLP

Pages

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS